Protalix BioTherapeutics, Inc. (PLX) Current Ratio
- Current ratio · latest quarter: Value 2.94×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.94× | Current assets / current liabilities. $92.22M ÷ $31.39M ≈ 2.94× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 92.22M USD | Assets, Current |
| Current obligations | 31.39M USD | Liabilities, Current |
| Cash and equivalents | 27.42M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 16.50M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 32.29M USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $92.22M | $31.39M | $27.42M | (m) | $16.50M | $32.29M | (m) | (m) | 2.94× |
| 2026-03-31 | $86.36M | $27.39M | $41.00M | (m) | $2.94M | $30.47M | (m) | (m) | 3.15× |
| 2025-12-31 | $66.67M | $26.52M | $14.68M | (m) | $8.84M | $25.73M | (m) | (m) | 2.51× |
| 2025-09-30 | $66.50M | $21.95M | $13.65M | (m) | $14.43M | $21.25M | (m) | (m) | 3.03× |
| 2025-06-30 | $65.48M | $24.09M | $17.89M | (m) | $9.44M | $21.13M | (m) | (m) | 2.72× |
| 2025-03-31 | $60.51M | $24.32M | $19.46M | (m) | $4.67M | $19.51M | (m) | (m) | 2.49× |
| 2024-12-31 | $60.08M | $25.62M | $19.76M | (m) | $2.91M | $21.24M | (m) | (m) | 2.34× |
| 2024-09-30 | $47.85M | $24.22M | $27.41M | (m) | $2.19M | $17.20M | $19.58M | (m) | 1.98× |
| 2024-06-30 | $77.37M | $57.97M | $23.40M | (m) | $10.13M | $20.72M | $19.34M | (m) | 1.33× |
| 2024-03-31 | $75.40M | $54.83M | $27.21M | (m) | $3.76M | $22.35M | $18.77M | (m) | 1.38× |
| 2023-12-31 | $69.93M | $45.53M | $23.63M | (m) | $5.27M | $19.05M | (m) | (m) | 1.54× |
| 2023-09-30 | $72.62M | $43.36M | $20.41M | (m) | $8.94M | $21.58M | $18.74M | (m) | 1.67× |
| 2023-06-30 | $73.58M | $23.11M | $48.18M | (m) | $4.05M | $19.64M | $18.55M | (m) | 3.18× |
| 2023-03-31 | $55.40M | $31.52M | $33.04M | (m) | $1.30M | $20.30M | (m) | (m) | 1.76× |
| 2022-12-31 | $44.88M | $32.43M | $17.11M | (m) | $4.59M | $16.80M | $12.27M | (m) | 1.38× |
| 2022-09-30 | $45.76M | $34.30M | $10.72M | (m) | $8.65M | $14.56M | (m) | (m) | 1.33× |
| 2022-06-30 | $49.70M | $30.96M | $12.49M | (m) | $2.02M | $16.51M | (m) | (m) | 1.61× |
| 2022-03-31 | $56.54M | $35.33M | $16.89M | (m) | $5.91M | $16.59M | (m) | (m) | 1.60× |
| 2021-12-31 | $61.67M | $33.18M | $38.98M | (m) | $3.44M | $17.95M | $16.43M | (m) | 1.86× |
| 2021-09-30 | $71.22M | $42.76M | $10.64M | (m) | $5.56M | $14.73M | (m) | (m) | 1.67× |
| 2021-06-30 | $95.92M | $96.25M | $33.88M | (m) | $2.33M | $13.64M | (m) | (m) | 1.00× |
| 2021-03-31 | $90.70M | $80.86M | $19.83M | (m) | $4.60M | $13.91M | (m) | (m) | 1.12× |
| 2020-12-31 | $55.72M | $86.47M | $18.27M | (m) | $2.00M | $13.08M | $13.93M | (m) | 0.64× |
| 2020-09-30 | $60.33M | $43.90M | $13.53M | (m) | $3.15M | $13.28M | (m) | (m) | 1.37× |
| 2020-06-30 | $54.21M | $42.41M | $4.84M | (m) | $5.26M | $11.06M | (m) | (m) | 1.28× |
| 2020-03-31 | $57.77M | $47.63M | $14.17M | (m) | $8.88M | $9.49M | (m) | (m) | 1.21× |
| 2019-12-31 | $32.48M | $40.17M | $17.79M | (m) | $4.70M | $8.15M | $11.90M | (m) | 0.81× |
| 2019-09-30 | $40.44M | $33.32M | $21.44M | (m) | $8.72M | $7.53M | (m) | (m) | 1.21× |
| 2019-06-30 | $41.60M | $25.99M | $25.10M | (m) | $7.26M | $7.00M | (m) | (m) | 1.60× |
| 2019-03-31 | $47.34M | $27.04M | $30.36M | (m) | $8.56M | $6.71M | (m) | (m) | 1.75× |
| 2018-12-31 | $52.98M | $25.35M | $37.81M | (m) | $4.73M | $8.57M | $10.27M | (m) | 2.09× |
| 2018-09-30 | $57.34M | $24.34M | $41.87M | (m) | $4.89M | $7.96M | (m) | (m) | 2.36× |
| 2018-06-30 | $43.05M | $18.49M | $28.33M | (m) | $5.25M | $6.98M | (m) | (m) | 2.33× |
| 2018-03-31 | $55.69M | $24.15M | $41.32M | (m) | $4.76M | $7.02M | (m) | (m) | 2.31× |
| 2017-12-31 | $62.65M | $22.75M | $51.16M | (m) | $1.72M | $7.83M | (m) | (m) | 2.75× |
| 2017-09-30 | $51.15M | $26.59M | $33.48M | (m) | $7.29M | $7.48M | (m) | (m) | 1.92× |
| 2017-06-30 | $48.89M | $19.12M | $34.53M | (m) | $3.00M | $7.06M | (m) | (m) | 2.56× |
| 2017-03-31 | $61.54M | $20.29M | $48.02M | (m) | $2.74M | $7.10M | (m) | (m) | 3.03× |
| 2016-12-31 | $71.87M | $66.21M | $63.28M | (m) | $693.00K | $5.25M | $7.50M | (m) | 1.09× |
| 2016-09-30 | $59.65M | $10.33M | $51.32M | (m) | $2.10M | $4.86M | (m) | (m) | 5.77× |
| 2016-06-30 | $67.64M | $11.46M | $54.63M | (m) | $1.49M | $6.07M | (m) | (m) | 5.90× |
| 2016-03-31 | $76.27M | $9.28M | $66.67M | (m) | (m) | $5.74M | (m) | (m) | 8.22× |
| 2015-12-31 | $85.88M | $11.23M | $76.37M | (m) | (m) | $5.77M | $5.53M | (m) | 7.64× |
| 2015-09-30 | $47.88M | $22.85M | $34.25M | (m) | $4.57M | $6.34M | (m) | (m) | 2.09× |
| 2015-06-30 | $53.87M | $25.52M | $43.24M | (m) | $1.94M | $6.37M | (m) | (m) | 2.11× |
| 2015-03-31 | $59.58M | $26.55M | $47.96M | (m) | $1.82M | $6.88M | (m) | (m) | 2.24× |
| 2014-12-31 | $65.52M | $64.35M | $54.77M | (m) | (m) | $3.45M | $6.80M | (m) | 1.02× |
| 2014-09-30 | $71.21M | $24.38M | $60.32M | (m) | $1.99M | $6.83M | (m) | (m) | 2.92× |
| 2014-06-30 | $82.36M | $27.18M | $71.14M | (m) | $2.10M | $7.13M | (m) | (m) | 3.03× |
| 2014-03-31 | $88.56M | $26.78M | $77.69M | (m) | $1.74M | $6.53M | (m) | (m) | 3.31× |
| 2013-12-31 | $97.90M | $26.70M | $86.40M | (m) | $2.09M | $7.96M | (m) | (m) | 3.67× |
| 2013-09-30 | $105.20M | $25.23M | $91.40M | (m) | $2.05M | $7.58M | (m) | (m) | 4.17× |
| 2013-06-30 | $45.93M | $26.63M | $33.13M | (m) | $2.03M | $7.19M | (m) | (m) | 1.72× |
| 2013-03-31 | $52.89M | $24.41M | $41.87M | (m) | $1.70M | $5.77M | (m) | (m) | 2.17× |
| 2012-12-31 | $61.17M | $25.75M | $52.03M | (m) | $1.41M | $4.04M | (m) | (m) | 2.38× |
| 2012-09-30 | $59.58M | $20.43M | $50.22M | (m) | $4.03M | $2.06M | (m) | (m) | 2.92× |
| 2012-06-30 | $65.89M | $21.33M | $59.28M | (m) | $1.54M | $1.03M | (m) | (m) | 3.09× |
| 2012-03-31 | $49.84M | $17.72M | $45.60M | (m) | $815.00K | $263.00K | (m) | (m) | 2.81× |
| 2011-12-31 | $32.49M | $18.69M | $27.00M | (m) | $1.37M | $279.00K | (m) | (m) | 1.74× |
| 2011-09-30 | $40.28M | $18.31M | $34.56M | (m) | $2.28M | $427.00K | (m) | (m) | 2.20× |
| 2011-06-30 | $51.20M | $20.28M | $44.05M | (m) | $1.72M | $537.00K | (m) | (m) | 2.52× |
| 2010-12-31 | $46.33M | $18.90M | $35.90M | (m) | $7.01M | $1.19M | (m) | (m) | 2.45× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |